Skip to Content

Tag: Obstructive Sleep Apnea

Also Noted

Apnimed looks forward to Phase 3 studies 

October 17, 2022HME News Staff

CAMBRIDGE, Mass. – Apnimed, a clinical-stage pharmaceutical company focused on developing oral pharmacologic therapies to treat obstructive sleep apnea (OSA) and related disorders, has announced positive topline results from the MARIPOSA Phase 2b trial – an efficacy, safety and dose-finding study of one-month duration. The results were positive for the company’s lead candidate for OSA, AD109 (atomoxetine + aroxybutynin). The primary endpoint showed a statistically significant...

Apnimed, Obstructive Sleep Apnea

Read Full Articlered right arrow icon

Also Noted

ProSomnus secures $30M in financing 

August 29, 2022HME News Staff

SAN FRANCISCO – ProSomnus Sleep Technologies, a manufacturer of oral appliance therapy devices, has announced definitive agreements with institutional investors led by funds affiliated with or managed by Cohanzick Management and CrossingBridge Advisors. The financing - $30 million of debt comprised of two tranches: $15 million of senior secured convertible notes and $15 million of junior secured convertible notes with maturities of 36 months and 40 months, respectively – will support...

Obstructive Sleep Apnea, Oral appliance therapy, ProSomnus

Read Full Articlered right arrow icon

Also Noted

Signifier receives significant investment

March 24, 2022HME News Staff

BOSTON – Signifier Medical Technologies, a Boston-based medical technology company, has announced that Waha Capital PJSC, Angelus Sano Fund L.P., Segulah Medical Acceleration AB and certain other individual investors have collectively invested approximately $49 million in the purchase of existing shares in the company from shareholders unrelated to the board and management. Signifier's eXciteOSA medical device for the treatment of sleep disordered breathing has been launched in...

eXcite, Obstructive Sleep Apnea, Signifier Medical Technologies

Read Full Articlered right arrow icon


ResMed survey outlines what’s keeping Americans up at night 

March 15, 2022HME News Staff

SAN DIEGO – About 52% of Americans reported snoring or being told they snore, but only 33% are concerned about the associated health implications, according to ResMed’s 2022 Global Sleep Surveys.  “Sleep quality can be impacted by lifestyle changes and poor habits, but many people are struggling with undiagnosed conditions that may be the root cause,” said Carlos M. Nunez, M.D., ResMed’s chief medical officer. “Sleep apnea is a serious health concern, but...

CPAP Device, Obstructive Sleep Apnea, ResMed, sleep survey

Read Full Articlered right arrow icon

Also Noted

AirAvant tapped to serve veterans

November 2, 2021HME News Staff

DEERFIELD, Fla. – AirAvant Medical and First Nation Group have partnered to provide the FDA-cleared Bongo Rx Expiratory Positive Airway Pressure device to veterans and active-duty military members suffering from obstructive sleep apnea. First Nation Group is a medical-surgical supplier for all federal government agencies. “The opportunity to proudly serve veterans attracted AirAvant Medical to the partnership,” said Bruce Sher, co-president and co-founder. “It’s an honor...

AirAvant, Bongo Rx, Obstructive Sleep Apnea

Read Full Articlered right arrow icon

Jim Hollingshead


ResMed buys HST company

October 4, 2021HME News Staff

SAN DIEGO – ResMed has bought Ectosense, which makes the NightOwl home sleep test.  The NightOwl, approved by the U.S. Food and Drug Administration, is currently sold in the United States, Australia, New Zealand, India and parts of Europe. ResMed has distributed the NightOwl, under the brand ResMed onesleeptest, in Australia, New Zealand and India since 2020, and has been a minority investor in Ectosense since July 2020.  "Sleep labs and home tests each have critical roles to...

CPAP Therapy, Ectosense, Home Sleep Testing, NightOwl, Obstructive Sleep Apnea, ResMed

Read Full Articlered right arrow icon


Costly OSA: CDC enlists AASM in raising awareness

September 28, 2021HME News Staff

DARIEN, Ill. – The Centers for Disease Control and Prevention has awarded a grant to the American Academy of Sleep Medicine for a new awareness program focused on improving recognition of obstructive sleep apnea.  Nearly 30 million American adults have OSA and 80% are undiagnosed, costing the U.S. more than $149 billion annually in increased health care and mental health care costs, lost work productivity and increased accidents, according to a press release.  “Millions...

AASM, American Academy of Sleep Medicine, Obstructive Sleep Apnea, osa

Read Full Articlered right arrow icon

Seema Khosla

Specialty Providers

Sleep app puts ‘patients at the center’

August 27, 2021Tracy Orzel

DARIEN, Ill. – A proposed web-based app called “MySleepVillage” took second place in the American Academy of Sleep Medicine’s first ever Change Agents, a contest designed to generate creative ideas for diagnosing and treating obstructive sleep apnea.  The app aims to streamline patient communication and testing; connect to physicians, insurers and medical equipment companies; and provide options for remote monitoring of CPAP usage. The team behind it estimates that...

AASM, American Academy of Sleep Medicine, Obstructive Sleep Apnea, Sleep Therapy

Read Full Articlered right arrow icon

Also Noted

AHA releases statement on OSA and cardiovascular disease

June 29, 2021HME News Staff

YARMOUTH, Maine – Obstructive sleep apnea is often under recognized and understated in cardiovascular practice, despite its high prevalence in patients with heart diseases and the vulnerability of cardiac patients to OSA-related stressors and adverse cardiovascular outcomes, according to a new scientific statement from the American Heart Association. “We recommend screening for OSA in patients with resistant/poorly controlled hypertension, pulmonary hypertension, and recurrent atrial...

American Heart Association, Cardiovascular Disease, Obstructive Sleep Apnea, scientific statement

Read Full Articlered right arrow icon

Also Noted

Oventus highlights DTC business

June 21, 2021HME News Staff

BRISBANE, Australia – Oventus Medical says current data indicate that 60% of all patient referrals are coming direct-to-consumer from through two websites: and Additionally, the company says the number of telehealth consultations scheduled has increased 25% in the current quarter compared to the previous quarter. “Since Oventus launched its telehealth initiative as a result of COVID-19, the patient funnel has captured more than 2,000 patients,” the company...

CPAP Alternative, direct-to-consumer, O2Vent, Obstructive Sleep Apnea, Oventus Medical

Read Full Articlered right arrow icon